loader2
Partner With Us NRI

Lactose (India) Ltd share Price Today

Company details

136.00
146.90
40.20
173.65
6M Return 72.67%
1Y Return 182.18%
Mkt Cap.(Cr) 172.47
Volume 5,300
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 5,300

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Lactose (India) Ltd shares SWOT Analysis

Strengths (4)

  • Company with high TTM EPS Growth
  • Companies with rising net profit margins - quarterly as well as TTM basis
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (2)

  • Promoters increased pledged shares QoQ
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (3)

  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • Highest Recovery from 52 Week Low

Threats (2)

  • Promoter decreasing their shareholding
  • RSI indicating price weakness

Resistance and support

R1 144.6
R2 151.2
R3 155.5
Pivot

140.28

S1 133.7
S2 129.4
S3 122.8
EMA SMA
144.4
144.1
133.8
113.9
146.8
147.7
138.2
106.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ANKIT AGARWAL Bulk Sell 2024-02-29 147.9 86562 BSE
MABLE RAJESH Bulk Purchase 2019-04-22 28.01 51000 BSE
MANGAL SAVITRI BIZCON PRIVATE LIMITED Bulk Sell 2018-02-23 120 109277 BSE
Name Category Shares
SANGITA MAHESHWARI PROMOTER 30.73%
ATUL MAHESHWARI PROMOTER 10.81%
PUSHPA SURAJ MAHESHWARI PROMOTER 0.9%
SHYAMSUNDER BHORILAL TOSHNIWAL PROMOTER 5.96%
MADHUSHA LIFECARE PVT. LTD PROMOTER 4.57%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Lactose (India) Ltd Stocks COMPARISON

Financials( in Cr) Lactose (India) Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Zydus Lifesciences Ltd Divis Laboratories Ltd
Price 137.00 1,539.30 1,482.30 1,080.65 4,058.55
% Change -3.04 -0.11 2.77 -0.71 1.05
Mcap Cr 172.47 369,329.64 119,676.01 108,738.68 107,741.92
Revenue TTM Cr 65.80 43,885.68 15,790.60 17,237.40 7,767.51
Net Profit TTM Cr 1.21 8,560.84 2,513.47 1,997.30 1,823.38
PE TTM 33.72 39.42 27.36 28.41 77.12
1 Year Return 182.18 64.20 60.26 113.46 24.30
ROCE 9.27 16.79 14.76 16.25 19.30
ROE 3.03 16.46 10.66 14.05 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 40.56 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 41,960.24 -29,509.50
LAST 3M 102,987.80 -35,737.56
LAST 6M 169,824.52 46,518.61
LAST 12M 263,691.56 126,663.80

Lactose (India) Ltd Information

Stock PE (TTM)
33.72
Promoter Holding
53.65%
Book Value
33.6196
ROCE
9.27%
ROE
3.03%
Description
  • Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad. The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose. In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section. During the year 1995-96, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder. During the year 2004-05, the company streamlined their pharmaceutical plant and entered into long-term contract manufacturing for one of the leading multinational company. They invested substantially in upgrading and renovating the Pharmaceutical facilities as per the requirement of the new Schedule M, as per the directives from the Food and Drug Administration. Also, they started a new equipment manufacture, assemble and export for Projects division in Kandla SEZ (Special Economic Zone). During the year 2006-07, the company undertook major expansion programme at their existing production site for manufacturing of value added product "LACTULOSE" which is a forward integration of their existing product "LACTOSE". During the year 2007-08, the company successfully implemented the task undertaken last year and commissioned the new liquid orals division. During the year 2008-09, the company started manufacturing of Liquid Formulations. The Company in 2010, formed strategic alliance with Kerry Group of Ireland for contract manufacturing Of lactose 10,000 Mt / Annum. It started manufacturing for Dr Reddy`s for their Liquid Oral Bottles in 2015. In 2016, it started Lactulose Manufacturing API Plant. In 2022, it started own marketing & sales of Lactose Monohydrate under the banner of Lactose (India) Limited. The Company in 2023, launched production of Lactulose with state of art manufacturing facility. The Plant produces Lactulose Concentrate USP & Lactulose Solution USP/EP. It broadened the horizons by getting into contract manufacturing of Tablets, Liquid orals & Manufacturing of Finished Formulations.

Registered Address

Survey No 6, Village Poicha (Rania) Savli, Vadodara, Gujarat, 391780

Tel : 91-02667-244308/244729
Email : lil:lactoseindialimited.com, cs.lactose:gmail.com
Website : http://www.lactoseindialimited.com
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524202
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE058I01013

FAQ’s on Lactose (India) Ltd Shares

You can buy Lactose (India) Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lactose (India) Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 22, 2024 04:01 PM the closing price of Lactose (India) Ltd was Rs.137.00.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 22, 2024 04:01 PM, the market cap of Lactose (India) Ltd stood at Rs. 172.47.

The latest PE ratio of Lactose (India) Ltd as of May 22, 2024 04:01 PM is 33.72

The latest PB ratio of Lactose (India) Ltd as of May 22, 2024 04:01 PM is 0.24

The 52-week high of Lactose (India) Ltd share price is Rs. 173.65 while the 52-week low is Rs. 40.20

Download App

Download Our App

Play Store App Store
market app